Charles River Laboratories Current Ratio 2010-2024 | CRL

Current and historical current ratio for Charles River Laboratories (CRL) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Charles River Laboratories current ratio for the three months ending March 31, 2024 was 1.75.
Charles River Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $1.67B $0.96B 1.75
2023-12-31 $1.61B $1.06B 1.53
2023-09-30 $1.44B $0.99B 1.45
2023-06-30 $1.51B $1.01B 1.49
2023-03-31 $1.45B $0.98B 1.48
2022-12-31 $1.44B $1.09B 1.32
2022-09-30 $1.42B $1.01B 1.40
2022-06-30 $1.39B $1.05B 1.33
2022-03-31 $1.33B $0.99B 1.34
2021-12-31 $1.27B $1.03B 1.23
2021-09-30 $1.38B $0.98B 1.40
2021-06-30 $1.27B $0.93B 1.36
2021-03-31 $1.42B $0.80B 1.77
2020-12-31 $1.20B $0.84B 1.43
2020-09-30 $1.14B $0.79B 1.45
2020-06-30 $1.24B $0.73B 1.70
2020-03-31 $1.21B $0.69B 1.75
2019-12-31 $1.02B $0.71B 1.44
2019-09-30 $0.97B $0.68B 1.43
2019-06-30 $1.01B $0.64B 1.59
2019-03-31 $0.87B $0.53B 1.64
2018-12-31 $0.90B $0.56B 1.61
2018-09-30 $0.84B $0.54B 1.55
2018-06-30 $0.89B $0.52B 1.72
2018-03-31 $0.84B $0.41B 2.07
2017-12-31 $0.83B $0.46B 1.78
2017-09-30 $0.78B $0.42B 1.88
2017-06-30 $0.74B $0.42B 1.74
2017-03-31 $0.70B $0.38B 1.83
2016-12-31 $0.66B $0.43B 1.53
2016-09-30 $0.66B $0.41B 1.59
2016-06-30 $0.70B $0.41B 1.70
2016-03-31 $0.64B $0.31B 2.06
2015-12-31 $0.56B $0.31B 1.79
2015-09-30 $0.58B $0.31B 1.84
2015-06-30 $0.63B $0.28B 2.28
2015-03-31 $0.61B $0.27B 2.27
2014-12-31 $0.58B $0.30B 1.97
2014-09-30 $0.61B $0.28B 2.14
2014-06-30 $0.59B $0.27B 2.18
2014-03-31 $0.59B $0.24B 2.47
2013-12-31 $0.55B $0.25B 2.24
2013-09-30 $0.55B $0.24B 2.33
2013-06-30 $0.52B $0.23B 2.30
2013-03-31 $0.49B $0.33B 1.49
2012-12-31 $0.49B $0.34B 1.42
2012-09-30 $0.46B $0.33B 1.41
2012-06-30 $0.45B $0.33B 1.38
2012-03-31 $0.44B $0.22B 1.95
2011-12-31 $0.43B $0.22B 1.96
2011-09-30 $0.46B $0.22B 2.04
2011-06-30 $0.55B $0.28B 1.98
2011-03-31 $0.56B $0.31B 1.82
2010-12-31 $0.55B $0.26B 2.13
2010-09-30 $0.53B $0.24B 2.22
2010-06-30 $0.61B $0.25B 2.47
2010-03-31 $0.61B $0.25B 2.48
2009-12-31 $0.60B $0.25B 2.39
2009-09-30 $0.57B $0.25B 2.23
2009-06-30 $0.57B $0.27B 2.11
2009-03-31 $0.58B $0.28B 2.08
Sector Industry Market Cap Revenue
Medical Medical Services $11.242B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $115.971B 14.14
Cencora (COR) United States $44.597B 17.39
ICON (ICLR) Ireland $27.199B 25.68
DiDi Global (DIDIY) China $17.303B 0.00
Avantor (AVTR) United States $14.163B 20.85
CochLear (CHEOY) Australia $14.103B 0.00
Viatris (VTRS) United States $14.098B 4.21
Revvity (RVTY) United States $13.345B 23.41
Medpace Holdings (MEDP) United States $13.053B 42.95
Natera (NTRA) United States $13.015B 0.00
Solventum (SOLV) United States $9.430B 0.00
Sonic Healthcare (SKHHY) Australia $8.373B 0.00
HealthEquity (HQY) United States $6.385B 40.99
Bausch + Lomb (BLCO) Canada $5.974B 23.92
Organon (OGN) United States $5.395B 5.12
Doximity (DOCS) United States $5.233B 36.65
PACS (PACS) United States $4.921B 0.00
Life Times (LTH) United States $4.146B 43.44
Sotera Health (SHC) United States $3.705B 18.18
Surgery Partners (SGRY) United States $3.692B 33.78
GoodRx Holdings (GDRX) United States $3.189B 121.43
Agilon Health (AGL) United States $2.834B 0.00
Progyny (PGNY) United States $2.646B 45.56
AMN Healthcare Services Inc (AMN) United States $2.167B 8.59
Premier (PINC) United States $2.051B 8.78
BrightSpring Health Services (BTSG) United States $2.004B 0.00
Alignment Healthcare (ALHC) United States $1.925B 0.00
Teladoc Health (TDOC) United States $1.542B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.467B 0.00
Establishment Labs Holdings (ESTA) $1.251B 0.00
CareDx (CDNA) United States $0.942B 0.00
GeneDx Holdings (WGS) United States $0.831B 0.00
InnovAge Holding (INNV) United States $0.825B 0.00
Embecta (EMBC) United States $0.760B 5.16
Auna S.A (AUNA) Luxembourg $0.657B 0.00
Pediatrix Medical (MD) United States $0.633B 6.71
COMPASS Pathways (CMPS) United Kingdom $0.499B 0.00
Sharecare (SHCR) United States $0.497B 0.00
Enhabit (EHAB) United States $0.476B 47.45
Sonida Senior Living (SNDA) United States $0.407B 0.00
QDM (QDMI) Hong Kong, SAR China $0.353B 9.24
ModivCare (MODV) United States $0.335B 6.27
DocGo (DCGO) United States $0.314B 17.17
LifeMD (LFMD) United States $0.274B 0.00
MultiPlan (MPLN) United States $0.258B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
Beauty Health (SKIN) United States $0.221B 0.00
Biodesix (BDSX) United States $0.203B 0.00
Ascend Wellness Holdings (AAWH) United States $0.194B 0.00
So-Young (SY) China $0.100B 48.51
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.043B 5.82
Co-Diagnostics (CODX) United States $0.041B 0.00
Oncology Institute (TOI) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.034B 0.00
Nutex Health (NUTX) United States $0.034B 0.00
OncoCyte (OCX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.024B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
TRxADE HEALTH (MEDS) United States $0.021B 0.00
Singular Genomics Systems (OMIC) United States $0.020B 0.00
KindlyMD (KDLY) $0.017B 0.00
BIMI Holdings (BIMI) United States $0.016B 0.00
BioNexus Gene Lab (BGLC) $0.009B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.005B 0.00
OpGen (OPGN) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00